Enzymes, inhibition, substrate uncompetitive

Fig. 5.16. Enzyme mechanism with uncompetitive substrate inhibition.

Enzyme reaction kinetics were modelled on the basis of rapid equilibrium assumption. Rapid equilibrium condition (also known as quasi-equilibrium) assumes that only the early components of the reaction are at equilibrium.8-10 In rapid equilibrium conditions, the enzyme (E), substrate (S) and enzyme-substrate (ES), the central complex equilibrate rapidly compared with the dissociation rate of ES into E and product (P ). The combined inhibition effects by 2-ethoxyethanol as a non-competitive inhibitor and (S)-ibuprofen ester as an uncompetitive inhibition resulted in an overall mechanism, shown in Figure 5.20. 

Full and partial uncompetitive inhibitory mechanisms, (a) Reaction scheme for full uncompetitive inhibition indicates ordered binding of substrate and inhibitor to two mutually exclusive sites. The presence of inhibitor prevents release of product, (b) Lineweaver-Burk plot for full uncompetitive inhibition reveals a series of parallel lines and an increase in the 1/v axis intercept to infinity at infinitely high inhibitor concentrations. In this example, Ki = 3 iulM. (c) Replot of Lineweaver-Burk slopes from (b) is linear, confirming a full inhibitory mechanism, (d) Reaction scheme for partial uncompetitive inhibition indicates random binding of substrate and inhibitor to two mutually exclusive sites. The presence of inhibitor alters the rate of release of product (by a factor P) and the affinity of enzyme for substrate (by a factor a) to an identical degree, while the presence of substrate alters the affinity of enzyme for inhibitor by a. (e) Lineweaver-Burk plot for partial uncompetitive inhibition reveals a series of parallel lines and an increase in the 1/v axis intercept to a finite value at infinitely high inhibitor concentrations. In this example, Ki = 3 iulM and a = = 0.5. (f) Replot of Lineweaver-Burk slopes from (e) is hyperbolic, confirming a partial inhibitory mechanism... 

Reversible inhibition of an enzyme is competitive, uncompetitive, or mixed. Competitive inhibitors compete with substrate by binding reversibly to the active site, but they are not transformed by the enzyme. Uncompetitive inhibitors bind only to the ES complex, at a site distinct from the active site. Mixed inhibitors bind to either E or ES, again at a site distinct from the active site. In irreversible inhibition an inhibitor binds permanently to an active site by forming a covalent bond or a veiy stable noncovalent interaction. 

Uncompetitive inhibitors bind only to the enzyme-substrate complex and not to the free enzyme. For example, the substrate binds to the enzyme causing a conformational change which reveals the inhibitor binding site, or it could bind directly to the enzyme-bound substrate. In neither case does the enzyme compete for the same binding site, so the inhibition cannot be overcome by increasing the substrate concentration. Scheme 5.A5.2 below illustrates this uncompetitive behaviour. 

Types of enzyme inhibition, (a) A competitive inhibitor competes with the substrate for binding at the same site on the enzyme, (b) A noncompetitive inhibitor binds to a different site but blocks the conversion of the substrate to products, (c) An uncompetitive inhibitor binds only to the enzyme—substrate complex. (E = enzyme S = substrate.)... 

In summary, the quantity [I]50 cannot simply be equated with the inhibition constant K]. This can be done only if the following conditions are met (i) existence of non-competitive or uncompetitive inhibition and (ii) saturation of the enzyme by substrate. 

The characteristics of the double reciprocal plots given by Equation (5.149), Equation (5.154), and Equation (5.155) determine what kind of enzyme inhibition may occur competitive, noncompetitive, or uncompetitive. In a given concentration of enzyme and inhibitor, the substrate concentration is changed and the double reciprocal plot of 1/V against 1/[A] is drawn. Figure 5.24a illustrates the double... 

Another mode of inhibition, termed uncompetitive inhibition (Figure 8-9) represents a further limiting case in which the inhibitor only binds to the enzyme-substrate complex, and in doing so blocks turnover. The equation for this class of inhibition is ... 

MichaeUs-Menten kinetics predict that as the concentration of the substrate increases, the rate increases hyperbolically. However, some enzymes exist in which a maximum velocity is obtained at low substrate concentration, but further increases in the substrate concentration lead to a decrease in velocity. This effect is known as substrate inhibition and can eventually lead to complete enzyme inhibition or partial enzyme inhibition. It is thought that substrate inhibition occurs if two substrate molecules bind to the enzyme simultaneously in an incorrect orientation and produce an inactive E S S complex, analogous to that discussed for uncompetitive inhibition. The rate of the enzyme reaction that undergoes substrate inhibition is given by Equation 17, where K represents the... 

Uncompetitive inhibition is distinguished by the fact that the inhibitor binds only to the enzyme-substrate complex. The uncompetitive inhibitor s binding site is created only on interaction of the enzyme and substrate (see Figure 8.15C), Uncompetitive inhibition cannot be overcome by the addition of more substrate. 

In noncompetitive inhibition, the inhibitor and substrate can bind simultaneously to an enzyme molecule at different binding sites (see Figure 8.1 5D). A noncompetitive inhibitor acts by decreasing the turnover number rather than by diminishing the proportion of enzyme molecules that arc bound to substrate. Noncompetitive inhibition, like uncompetitive inhibition, cannot be overcome by increasing the substrate concentration. A more complex pattern, called mixed inhibition, is produced when a single inhibitor both hinders the binding of substrate and decreases the turnover number of the enzyme. 

Enzyme inhibition can occur when a compound competes with substrate for the active site of the free enzyme, binds to the ES complex at a site removed from the active site, or binds to the free enzyme at a site removed from the active site. Three classes of enzyme inhibitors are described competitive, uncompetitive, and noncompetitive inhibitors. 

Most inhibition of enzymes is competitive, uncompetitive, or noncompetitive. Competitive inhibitors reversibly compete with substrate for the same site on free enzyme. Uncompetitive inhibitors bind only to the enzyme-substrate complex and not the free enzyme. Noncompetitive inhibitors can bind to both the enzyme and the enzyme-substrate complex. 

In uncompetitive inhibition the inhibitor binds only to the enzyme-substrate complex. It does not affect the binding of enzyme to substrate, but it does prevent the complex dissociating to give product. Thus, the uncompetitive inhibitor tends to stabilize the... 

Alternatively we could measure the 1C50 or the Ki (inhibitory constant) for the perpetrator. The A) of a perpetrator that is capable of inhibiting an enzyme (or transporter) is the dissociation constant for the enzyme-inhibitor complex. Accurate estimation of the A) requires, among other things, the appropriate definition or specification of the type of enzyme inhibition (e.g., competitive, noncompetitive, or uncompetitive). The appropriate in vitro experiments require that multiple concentrations of the inhibitor must be used as well as a range of substrate concentrations that embrace the substrate Km, and from these experiments both the type of inhibition elicited by the perpetrator can be deduced and the A) value for the perpetrator can be estimated. The Ki will have units of concentration. Alternatively, K values can be computed from /C50 values for an inhibitor. The /C50 is defined simply as the inhibitor concentration that decreases the biotransformation of a substrate at a single, specified concentration by 50%. This parameter obviously also has units of concentration (e.g., pM), and can be related to the Ki as follows. 

D23.4 Refer to eqns 23.26 and 23.27, which are the analogues of the Michaelis-Menten and Lineweaver-Burk equations (23.21 and 23,22), as well as to Figure 23.13, There are three major modes of inhibition that give rise to distinctly different kinetic behavior (Figure 23.13), In competitive inhibition the inhibitor binds only to the active site of the enzyme and thereby inhibits the attachment of the substrate. This condition corresponds to a > 1 and a = 1 (because ESI does not form). The slope of the Lineweaver-Burk plot increases by a factor of a relative to the slope for data on the uninhibited enzyme (a = a = I), The y-intercept does not change as a result of competitive inhibition, In uncompetitive inhibition, the inhibitor binds to a site of the enzyme that is removed from the active site, but only if the substrate is already present. The inhibition occurs because ESI reduces the concentration of ES, the active type of the complex, In this case a = 1 (because El does not form) and or > 1. The y-intercepl of the Lineweaver-Burk plot increases by a factor of a relative to they-intercept for data on the uninhibited enzyme, but the slope does not change. In non-competitive inhibition, the inhibitor binds to a site other than the active site, and its presence reduces the ability of the substrate to bind to the active site. Inhibition occurs at both the E and ES sites. This condition corresponds to a > I and a > I. Both the slope and y-intercept... 

Again, it is believed that this scenario occurs due to simultaneous binding of a second substrate molecule within the active site resulting in a type of uncompetitive inhibition. It remains unclear whether binding of the second substrate molecule results in a partial inhibition of binding of the first substrate molecule or whether the binding of this second molecule causes a conformational change in the enzyme active site that inhibits substrate turnover. 

Mechanisms of CYP inhibition can be broadly divided into two categories reversible inhibition and mechanism-based inactivation. Depending on the mode of interaction between CYP enzymes and inhibitors, reversible CYP inhibition is further characterized as competitive, noncompetitive, uncompetitive, and mixed (Ito et al., 1998b). Evaluation of reversible inhibition of CYP reactions is often conducted under conditions where M-M kinetics is obeyed. Based on the scheme illustrated in Fig. 5.1, various types of reversible inhibition are summarized in Table 5.1. Figure 5.1 depicts a simple substrate-enzyme complex during catalysis. In the presence of a reversible inhibitor, such a complex can be disrupted leading to enzyme inhibition. 

May be most inhibitors are mixed-type however competitive and non-competitive behaviors are frequently reported when one effect is significantly stronger than the other. Mixed-type inhibition, as non-competitive inhibition, can be partial or total depending on the activity of the tertiary enzyme-substrate-inhibitor complex. A particular case of mixed-type inhibition is uncompetitive inhibition in this case the enzyme has no preformed site for binding the inhibitor, that can only binds to the enzyme after the substrate has bound to it. This situation is not frequent, with the exception of the case when the substrate itself is the inhibitor in fact, uncompetitive inhibition by high substrate concentration is rather common in enzyme catalyzed reactions. 

It is a monomeric protein of M.W. about 70,000, shows Kj, values for L-tryptophan and dimethylallyl pyrophosphate of 0.067 and 0.2 mM, respectively, and seems to have a relatively low turnover number, about 7 sec . During studies on this enzyme it was observed (13) that agroclavlne and elymoclavine, the terminal alkaloids in the strain used for the isolation of the enzyme, inhibited purified DMAT synthetase. At concentrations of 3 mM ( v<750 mg/1) agroclavlne and elymoclavine inhibited the enzyme 90% and 70%, respectively. The inhibition is of a mixed or uncompetitive type as shown by kinetic analysis with either tryptophan or dimethylallyl pyrophosphate as the variable substrate (Fig. 6). Subsequently, feedback Inhibition by elymoclavine was also demonstrated by GrSger s group (3) for chanoclavlne cyclase and by us for anthranllate synthetase from... 

Consequently, it is possible to determine the inhibition mode of an enzyme by a particular inhibitor by simply observing the displacement of the response curves of a potentiometric electrode on which the enzyme is immobilized. Inhibition is competidve if the plateau that corresponds to the maximal response is unchanged. When the response to low substrate concentradons is not modified in the presence of inhibitors then the inhibition is uncompetitive. Non-competitive inhibition gives rise to a response curve that has no point in common with the response curve in the absence of the inhibitor. These results for simulated response have been confirmed experimentally [56]. 

Like a noncompetitive inhibitor, an uncompetitive inhibitor does not compete with the substrate since it binds to the enzyme—substrate complex but not to the free enzyme. Uncompetitive inhibition... 

The three most common types of inhibitors in enzymatic reactions are competitive, non-competitive, and uncompetitive. Competitive inliibition occurs when tlie substrate and inhibitor have similar molecules that compete for the identical site on the enzyme. Non-competitive inhibition results in enzymes containing at least two different types of sites. The inhibitor attaches to only one type of site and the substrate only to the other. Uncompetitive inhibition occurs when the inhibitor deactivates the enzyme substrate complex. The effect of an inhibitor is determined by measuring the enzyme velocity at various... 

Substrate and product inhibitions analyses involved considerations of competitive, uncompetitive, non-competitive and mixed inhibition models. The kinetic studies of the enantiomeric hydrolysis reaction in the membrane reactor included inhibition effects by substrate (ibuprofen ester) and product (2-ethoxyethanol) while varying substrate concentration (5-50 mmol-I ). The initial reaction rate obtained from experimental data was used in the primary (Hanes-Woolf plot) and secondary plots (1/Vmax versus inhibitor concentration), which gave estimates of substrate inhibition (K[s) and product inhibition constants (A jp). The inhibitor constant (K[s or K[v) is a measure of enzyme-inhibitor affinity. It is the dissociation constant of the enzyme-inhibitor complex. 

P-site ligands inhibit adenylyl cyclases by a noncompetitive, dead-end- (post-transition-state) mechanism (cf. Fig. 6). Typically this is observed when reactions are conducted with Mn2+ or Mg2+ on forskolin- or hormone-activated adenylyl cyclases. However, under- some circumstances, uncompetitive inhibition has been noted. This is typically observed with enzyme that has been stably activated with GTPyS, with Mg2+ as cation. That this is the mechanism of P-site inhibition was most clearly demonstrated with expressed chimeric adenylyl cyclase studied by the reverse reaction. Under these conditions, inhibition by 2 -d-3 -AMP was competitive with cAMP. That is, the P-site is not a site per se, but rather an enzyme configuration and these ligands bind to the post-transition-state configuration from which product has left, but before the enzyme cycles to accept new substrate. Consequently, as post-transition-state inhibitors, P-site ligands are remarkably potent and specific inhibitors of adenylyl cyclases and have been used in many studies of tissue and cell function to suppress cAMP formation. 

An inhibitor that binds exclusively to the ES complex, or a subsequent species, with little or no affinity for the free enzyme is referred to as uncompetitive. Inhibitors of this modality require the prior formation of the ES complex for binding and inhibition. Hence these inhibitors affect the steps in catalysis subsequent to initial substrate binding that is, they affect the ES —> ES1 step. One might then expect that these inhibitors would exclusively affect the apparent value of Vm and not influence the value of KM. This, however, is incorrect. Recall, as illustrated in Figure 3.1, that the formation of the ESI ternary complex represents a thermodynamic cycle between the ES, El, and ESI states. Hence the augmentation of the affinity of an uncompetitive inhibitor that accompanies ES complex formation must be balanced by an equal augmentation of substrate affinity for the El complex. The result of this is that the apparent values of both Vmax and Ku decrease with increasing concentrations of an uncompetitive inhibitor (Table 3.3). The velocity equation for uncompetitive inhibition is as follows ... 

---